Drawing for HEALTHY HUMAN HYDRATION PLUS

USPTO serial 90329620

HEALTHY HUMAN HYDRATION PLUS

Reviewed by CopyMark Law Group

Status 603
Filing date
Status date
Registration date
—
Examiner
KON, ELISSA GARBER
Law office
TMEG LAW OFFICE 106 - EXAMINING ATTORNEY ASSIGNED

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with HEALTHY HUMAN HYDRATION PLUS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

GREGORY FINCH

GREGORY FINCH FINCH PAOLINO, LLC91 RUTLEDGE AVENUECHARLESTON, SC 29401UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Effervescent vitamin tablets; Electrolyte replacement solutions; Mixed vitamin preparations; Multi-vitamin preparations; Vitamin supplement in tablet form for use in making an effervescent beverage when added to waterACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 9, 2022MAB3ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL—
Sep 9, 2022MAB3ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL—
Sep 9, 2022ABN3ABANDONMENT - AFTER EX PARTE APPEAL—
Sep 9, 2022EXPTEXPARTE APPEAL TERMINATED—
Jul 22, 2022EXFBEXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF—
Mar 14, 2022EXPIEX PARTE APPEAL-INSTITUTED—
Mar 14, 2022EXAFEXPARTE APPEAL RECEIVED AT TTAB—
Sep 13, 2021GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Sep 13, 2021GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 13, 2021CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 18, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 17, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 17, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 17, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 17, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 17, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 16, 2021DOCKASSIGNED TO EXAMINER—
Jan 24, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 23, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance